Influence of cytotoxicity on test results in the L5178Y TK+/- mouse lymphoma assay

Environmental and Molecular Mutagenesis

Volumn 27, Issue 1, 1996, Pages 75-78

  Oberly, T J ^a   Garriott, M L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Cytotoxicity; Relative total growth; Sensitivity

Indexed keywords

ACARICIDE; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIULCER AGENT; ANTIVIRUS AGENT; HERBICIDE; IMMUNOMODULATING AGENT; URETHAN DERIVATIVE;

ARTICLE; CARCINOGENICITY; CYTOTOXICITY; GENOTOXICITY; LYMPHOMA; MOUSE; NONHUMAN;

ANIMALS; ARTIFACTS; CARCINOGENS; CELL DIVISION; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; DATABASES, FACTUAL; DRUG TOXICITY; FALSE POSITIVE REACTIONS; HETEROZYGOTE; LEUKEMIA L5178; MICE; MUTAGENICITY TESTS; MUTAGENS; RATS; RETROSPECTIVE STUDIES; SALMONELLA TYPHIMURIUM; SENSITIVITY AND SPECIFICITY; THYMIDINE KINASE; TOXICOLOGY; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0029998856     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1996)27:1<75::AID-EM10>3.0.CO;2-G     Document Type: Article

References (22)

1. Amacher DE, Paillet SC, Turner GN, Ray VA, Salsburg DS (1980): Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells, II. Test validation and interpretation. Mutat Res 72:447-474.
2. Ames BN, McCann J, Yamasaki E (1975): Methods for detecting carcinogens and mutagens with the Salmonella/mammalian microsome mutagenicity test. Mutat Res 31:347-364.
3. Caldwell J (1993): Perspective on the usefulness of the mouse lymphoma assay as an indicator of a genotoxic carcinogen: Ten compounds which are positive in the mouse lymphoma assay but are not genotoxic carcinogens. Teratogen Carcinogen Mutagen 13:185-190.
4. +/- mouse lymphoma forward mutation assay. Environ Mutagen 6:423.
5. Cline JC, McMahon RE (1977): Detection of chemical mutagens: Use of concentration gradient plate in a high capacity screen. Res Commun Chem Pathol Pharmacol 16:525-533.
6. +/- mouse lymphoma mutagen/carcinogen assay system. Mutat Res 59:61-108.
7. Clive D, Caspary W, Kirby P, Krehl R, Moore M, Mayo J, Oberly TJ (1987): Guide for performing the mouse lymphoma assay for mammalian cell mutagenicity. Mutat Res 189:143-156.
8. Clive D, Bolcsfoldi G, Clements J, Cole J, Homna M, Majeska J, Moore M, Muller L, Myhr B, Oberly TJ, Oudelhkim M, Rudd C, Shimada H, Sofuni T, Thybaud V, Wilcox P (1995): Concensus agreement regarding protocol issues discussed during the mouse lymphoma workshop, Portland, Oregon, May 7, 1994. Environ Mol Mutagen 25:165-168.
9. Galloway S, Bean CL, Armstrong MA, Deasy D, Kraynak A, Bradley MO (1985): False positive in vitro chromosome aberration tests with non-mutagens at high concentrations and osmolalities. Environ Mutagen 7:48.
10. +/- mouse lymphoma assay. Environ Mol Mutagen 14:305.
11. Li AP, Aaron CS, Auletta AE, Dearfield KL, Riddle CJ, Slesinski RS, Stankowski LF (1991): An evaluation of the roles of mammalian cell mutation assays in the testing of chemical genotoxicity. Regul Toxicol Pharmacol 14:24-40.
12. McCann J, Choi E, Yamasaki E, Ames BN (1975): Detection of carcinogens as mutagens in the Salmonella/microsome test. Assay of 300 chemicals. Proc Natl Acad Sci USA 72:5135-5139.
13. Neal SB, Probst GS (1983): Chemically-induced sister chromatid exchange in vivo in bone marrow of Chinese hamsters. An evaluation of 24 compounds. Mutat Res 113:33-43.
14. +/- mouse lymphoma forward mutation assay using 42 chemicals. Mutat Res 125:291-306.
15. Oberly TJ, Bewsey BJ, Probst GS (1987). A procedure for the CHO-HGPRT mutation assay involving treatment of cells in suspension culture and selection of mutants in soft-agar. Mutat Res 182:99-111
16. Oberly TJ, Rexroat MA, Bewsey BJ, Richardson KK, Michaelis KC (1990): An evaluation of the CHO/HGPRT mutation assay involving suspension cultures and soft agar cloning: Results for 33 chemicals. Environ Mol Mutagen 16:260-271.
17. Parton JW, Probst GS, Garriott ML (1988): The in vivo effect of 2,6-xylidine on induction of micronuclei in mouse bone marrow cells. Mutat Res 206:281-283.
18. Preston RJ, Au W, Bender MA, Brewen JG, Carrano AV, Heddle JA, McFee AF, Wolff S, Wassom JS (1981): Mammalian in vivo and in vitro cytogenetic assays: A report of the U.S. EPA's Gen-Tox Program. Mutat Res 87:143-188.
19. Probst GS, Neal SB (1980): The induction of unscheduled DNA synthesis by antihistamines in primary hepatocyte culture. Cancer Lett 10:67-73
20. Rexroat MA, Oberly TJ, Bewsey BJ, Garriott ML (1995): The gradient plate assay: A modified Ames Assay used as a prescreen for the identification of bacterial mutagens. Mutat Res 341:185-192.
21. Tennant RW, Margolin BH, Shelby MD, Zeiger E, Haseman JK, Spalding J, Caspary W, Resnick M, Stasiewicz S, Anderson B, Minor R (1987): Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicology assays. Science 236:933-941.
22. Williams GM (1977): Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures. Cancer Res 37:1845-1851.